BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 32917861)

  • 21. Genome-wide prediction of conserved and nonconserved enhancers by histone acetylation patterns.
    Roh TY; Wei G; Farrell CM; Zhao K
    Genome Res; 2007 Jan; 17(1):74-81. PubMed ID: 17135569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DELTA: A Distal Enhancer Locating Tool Based on AdaBoost Algorithm and Shape Features of Chromatin Modifications.
    Lu Y; Qu W; Shan G; Zhang C
    PLoS One; 2015; 10(6):e0130622. PubMed ID: 26091399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chromatin immunoprecipitation from fixed clinical tissues reveals tumor-specific enhancer profiles.
    Cejas P; Li L; O'Neill NK; Duarte M; Rao P; Bowden M; Zhou CW; Mendiola M; Burgos E; Feliu J; Moreno-Rubio J; Guadalajara H; Moreno V; García-Olmo D; Bellmunt J; Mullane S; Hirsch M; Sweeney CJ; Richardson A; Liu XS; Brown M; Shivdasani RA; Long HW
    Nat Med; 2016 Jun; 22(6):685-91. PubMed ID: 27111282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Global analysis of histone modifications and long-range chromatin interactions revealed the differential cistrome changes and novel transcriptional players in human dilated cardiomyopathy.
    Liu CF; Abnousi A; Bazeley P; Ni Y; Morley M; Moravec CS; Hu M; Tang WHW
    J Mol Cell Cardiol; 2020 Aug; 145():30-42. PubMed ID: 32533974
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple CTCF sites cooperate with each other to maintain a TAD for enhancer-promoter interaction in the β-globin locus.
    Kang J; Kim YW; Park S; Kang Y; Kim A
    FASEB J; 2021 Aug; 35(8):e21768. PubMed ID: 34245617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Different enhancer classes in Drosophila bind distinct architectural proteins and mediate unique chromatin interactions and 3D architecture.
    Cubeñas-Potts C; Rowley MJ; Lyu X; Li G; Lei EP; Corces VG
    Nucleic Acids Res; 2017 Feb; 45(4):1714-1730. PubMed ID: 27899590
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RNA transcribed from a distal enhancer is required for activating the chromatin at the promoter of the gonadotropin α-subunit gene.
    Pnueli L; Rudnizky S; Yosefzon Y; Melamed P
    Proc Natl Acad Sci U S A; 2015 Apr; 112(14):4369-74. PubMed ID: 25810254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential regulation of chromatin structure of the murine 3' IgH enhancer and IgG2b germline promoter in response to lipopolysaccharide and CD40 signaling.
    Qin X; Tang H
    Mol Immunol; 2006 Mar; 43(8):1211-20. PubMed ID: 16099047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The immunoglobulin heavy-chain gene 3' enhancers deregulate bcl-2 promoter usage in t(14;18) lymphoma cells.
    Duan H; Heckman CA; Boxer LM
    Oncogene; 2007 Apr; 26(18):2635-41. PubMed ID: 17043638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integrative pan cancer analysis reveals epigenomic variation in cancer type and cell specific chromatin domains.
    Gopi LK; Kidder BL
    Nat Commun; 2021 Mar; 12(1):1419. PubMed ID: 33658503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Control of p53-dependent transcription and enhancer activity by the p53 family member p63.
    Karsli Uzunbas G; Ahmed F; Sammons MA
    J Biol Chem; 2019 Jul; 294(27):10720-10736. PubMed ID: 31113863
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proteasome inhibition creates a chromatin landscape favorable to RNA Pol II processivity.
    Kinyamu HK; Bennett BD; Bushel PR; Archer TK
    J Biol Chem; 2020 Jan; 295(5):1271-1287. PubMed ID: 31806706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loci-specific histone acetylation profiles associated with transcriptional coactivator p300 during early myoblast differentiation.
    Khilji S; Hamed M; Chen J; Li Q
    Epigenetics; 2018; 13(6):642-654. PubMed ID: 29927685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methods for ChIP-seq analysis: A practical workflow and advanced applications.
    Nakato R; Sakata T
    Methods; 2021 Mar; 187():44-53. PubMed ID: 32240773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiple mechanisms regulate H3 acetylation of enhancers in response to thyroid hormone.
    Præstholm SM; Siersbæk MS; Nielsen R; Zhu X; Hollenberg AN; Cheng SY; Grøntved L
    PLoS Genet; 2020 May; 16(5):e1008770. PubMed ID: 32453730
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-resolution genome-wide mapping of histone modifications.
    Roh TY; Ngau WC; Cui K; Landsman D; Zhao K
    Nat Biotechnol; 2004 Aug; 22(8):1013-6. PubMed ID: 15235610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simultaneous Mapping of Enhancers and Enhancer Rearrangements with Paired-End H3K27ac ChIP-seq.
    Antman I; Davis E; Abu-Kamel S; Hecht M; Drier Y
    Methods Mol Biol; 2022; 2535():131-140. PubMed ID: 35867228
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Super-enhancers are transcriptionally more active and cell type-specific than stretch enhancers.
    Khan A; Mathelier A; Zhang X
    Epigenetics; 2018; 13(9):910-922. PubMed ID: 30169995
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary effusion lymphoma enhancer connectome links super-enhancers to dependency factors.
    Wang C; Zhang L; Ke L; Ding W; Jiang S; Li D; Narita Y; Hou I; Liang J; Li S; Xiao H; Gottwein E; Kaye KM; Teng M; Zhao B
    Nat Commun; 2020 Dec; 11(1):6318. PubMed ID: 33298918
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The SWI/SNF chromatin remodelling complex is required for maintenance of lineage specific enhancers.
    Alver BH; Kim KH; Lu P; Wang X; Manchester HE; Wang W; Haswell JR; Park PJ; Roberts CW
    Nat Commun; 2017 Mar; 8():14648. PubMed ID: 28262751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.